{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:45:10Z","timestamp":1787586310872,"version":"build-2736575974"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":721,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jtct.2021.03.023","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T20:33:17Z","timestamp":1616790797000},"page":"489.e1-489.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases"],"prefix":"10.1016","volume":"27","author":[{"given":"Iman","family":"Shifa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Hazlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caylib","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R\u00e9gine","family":"Mydlarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie M.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Jamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.03.023_bib0001","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2007-03-081497","article-title":"Reversal of autoimmune disease in lupus-prone New Zealand black\/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells","volume":"110","author":"Smith-Berdan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.023_bib0002","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2004-12-4607","article-title":"Tolerance induction by bone marrow transplantation in a multiple sclerosis model","volume":"106","author":"Herrmann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.023_bib0003","series-title":"Thomas' Hematopoietic Cell Transplantation. 5th ed. West Sussex","first-page":"753","article-title":"Hematopoietic cell transplantation for autoimmune diseases","author":"Nash","year":"2016"},{"key":"10.1016\/j.jtct.2021.03.023_bib0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1191\/096120398678919903","article-title":"Stem cells transplantation\u2013a cure for autoimmune diseases","volume":"7","author":"Sherer","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.jtct.2021.03.023_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases.[Erratum appears in Bone Marrow Transplant. 2009;44:67 Note: Urban, C [added]]","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2021.03.023_bib0006","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703686","article-title":"Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases","volume":"30","author":"Hinterberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0007","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fimmu.2019.01570","article-title":"Allogeneic HSCT for autoimmune diseases: a retrospective study from the EBMT ADWP, IEWP, and PDWP working parties","volume":"10","author":"Greco","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0008","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases","volume":"1","author":"Snowden","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.03.023_bib0009","first-page":"1119","article-title":"Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer","volume":"32","author":"Franks","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jtct.2021.03.023_bib0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2021.03.023_bib0011","first-page":"23","article-title":"Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation","volume":"48","author":"Nelson","year":"1997","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.jtct.2021.03.023_bib0012","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/1529-0131(199908)42:8<1777::AID-ANR30>3.0.CO;2-C","article-title":"Long-term remission with allogeneic bone marrow transplantation in systemic lupus erythematosus","volume":"42","author":"Gur-Lavi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.03.023_bib0013","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bmt.1705359","article-title":"Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus","volume":"37","author":"Lu","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0014","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bmt.2016.21","article-title":"Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus","volume":"51","author":"Arita","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0015","first-page":"2513","article-title":"Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus","volume":"31","author":"Khorshid","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0016","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0961203316669242","article-title":"Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation","volume":"26","author":"Gladstone","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jtct.2021.03.023_bib0017","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/art.1780200502","article-title":"Bone marrow transplantation in patients with gold-induced marrow aplasia","volume":"20","author":"Baldwin","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.03.023_bib0018","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.20451","article-title":"Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism","volume":"50","author":"Burt","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.03.023_bib0019","first-page":"812","article-title":"Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant","volume":"33","author":"Lowenthal","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0020","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3109\/10428194.2012.680453","article-title":"Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia","volume":"53","author":"Itamura","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2021.03.023_bib0021","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41409-019-0635-9","article-title":"Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma","volume":"55","author":"Atoui","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0022","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/art.1780390727","article-title":"Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow-up","volume":"39","author":"McKendry","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.03.023_bib0023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1529-0131(199803)41:3<453::AID-ART11>3.0.CO;2-#","article-title":"Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation","volume":"41","author":"Snowden","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.03.023_bib0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1704183","article-title":"Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma","volume":"32","author":"Tapprich","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00281-017-0630-4","article-title":"Genetics of rheumatoid arthritis susceptibility, severity, and treatment response","volume":"39","author":"Viatte","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0026","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/art.21908","article-title":"Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis","volume":"54","author":"Nash","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.03.023_bib0027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bmt.1705611","article-title":"Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?","volume":"39","author":"Loh","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0028","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.300.6729.908","article-title":"Clearance of severe psoriasis after allogenic bone marrow transplantation","volume":"300","author":"Eedy","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.jtct.2021.03.023_bib0029","first-page":"31","article-title":"Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia","volume":"9","author":"Yin","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bmt.1700789","article-title":"Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation","volume":"19","author":"Kishimoto","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0031","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bmt.1702703","article-title":"Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy","volume":"26","author":"Adkins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0032","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0033","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00007890-200107270-00032","article-title":"Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?","volume":"72","author":"Chakrabarti","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2021.03.023_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.10169","article-title":"Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature","volume":"71","author":"Kanamori","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.bmt.1704146","article-title":"Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Kojima","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0036","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000089032","article-title":"Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation","volume":"212","author":"Masszi","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jtct.2021.03.023_bib0037","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjh.12026","article-title":"Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation","volume":"159","author":"Mori","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0038","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2012.08.021","article-title":"Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation","volume":"68","author":"Kaffenberger","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0039","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ard.2005.039479","article-title":"Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation","volume":"65","author":"Woods","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.03.023_bib0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00277-003-0819-6","article-title":"Resolution of Beh\u00e7et's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome","volume":"83","author":"Tomonari","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0041","unstructured":"Latinis KM, Brasington R, Adkins D. Behcet's resonsive to bone marrow transplant. Abstract No. 0602 at the American College of Rheumatology 67th Annual Meeting, October 23\u201328, 2003, Orlando, Florida, USA"},{"key":"10.1016\/j.jtct.2021.03.023_bib0042","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/rheumatology\/ken162","article-title":"Beh\u00e7et's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8","volume":"47","author":"Ahn","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtct.2021.03.023_bib0043","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2169\/internalmedicine.46.0291","article-title":"Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Beh\u00e7et's disease by up-front cord blood transplantation","volume":"46","author":"Nonami","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jtct.2021.03.023_bib0044","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/rheumatology\/ken413","article-title":"Resolution of Behcet's disease after non-myeloablative allogeneic stem cell transplant for acute myeloid leukaemia","volume":"48","author":"Lim","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtct.2021.03.023_bib0045","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/rheumatology\/ket479","article-title":"Bone marrow transplantation for Beh\u00e7et's disease: a case report and systematic review of the literature","volume":"53","author":"Soysal","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtct.2021.03.023_bib0046","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3904\/kjim.2014.29.1.123","article-title":"Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Kook","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jtct.2021.03.023_bib0047","doi-asserted-by":"crossref","first-page":"e17979","DOI":"10.1097\/MD.0000000000017979","article-title":"Intestinal Behcet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: a case report","volume":"98","author":"Asano","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtct.2021.03.023_bib0048","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bmt.1705372","article-title":"Allogeneic bone marrow transplantation (BMT) for refractory Beh\u00e7et's disease with severe CNS involvement","volume":"37","author":"Marmont","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0049","first-page":"580","article-title":"Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia","volume":"59","author":"Talbot","year":"1998","journal-title":"Hosp Med"},{"key":"10.1016\/j.jtct.2021.03.023_bib0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0016-5085(98)70525-6","article-title":"Course of Crohn's disease after allogeneic marrow transplantation","volume":"114","author":"Lopez-Cubero","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtct.2021.03.023_bib0051","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41409-020-0953-y","article-title":"A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn disease","volume":"55","author":"Burt","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0052","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.bmt.1700666","article-title":"Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis","volume":"19","author":"McAllister","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0053","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00277-003-0801-3","article-title":"Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis","volume":"83","author":"La Nasa","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0054","doi-asserted-by":"crossref","first-page":"P686","DOI":"10.1055\/s-0029-1238779","article-title":"Long-term follow-up of two patients with multiple sclerosis treated with allogeneic stem cell transplantation for chronic myeloid leukaemia","volume":"36","author":"Varga","year":"2009","journal-title":"Akt Neurol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archneurol.2010.117","article-title":"Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Lu","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0056","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archneurol.2008.522","article-title":"Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation","volume":"66","author":"Lu","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0057","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/1352458507076981","article-title":"Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis","volume":"13","author":"Jeffery","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jtct.2021.03.023_bib0058","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ana.24079","article-title":"Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica","volume":"75","author":"Greco","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0059","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/acn3.50843","article-title":"T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica","volume":"6","author":"Ceglie","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102110","article-title":"Allogeneic haematopoietic stem cell transplantation in a refractory case of neuromyelitis optica spectrum disorder","volume":"42","author":"Hau","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jtct.2021.03.023_bib0061","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/acr.22774","article-title":"Analysis of complete remission in systemic lupus erythematosus patients over a 32-year period","volume":"68","author":"Medina-Qui\u00f1ones","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jtct.2021.03.023_bib0062","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/03009740903042394","article-title":"Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up","volume":"39","author":"Tiippana-Kinnunen","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0063","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/annrheumdis-2014-207080","article-title":"Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms","volume":"75","author":"Ajeganova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.03.023_bib0064","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/annrheumdis-2017-211375","article-title":"Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study","volume":"77","author":"Akdemir","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.03.023_bib0065","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/annrheumdis-2018-214868","article-title":"Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status","volume":"78","author":"Boeters","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.03.023_bib0066","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s13555-019-0310-5","article-title":"Remission duration and long-term outcomes in patients with moderate-to-severe psoriasis treated by biologics or tofacitinib in controlled clinical trials: a 15-year single-center experience","volume":"9","author":"Huang","year":"2019","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jtct.2021.03.023_bib0067","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/art.40235","article-title":"Brief report: Drug-free long-term remission in severe Beh\u00e7et's disease following withdrawal of successful anti-tumor necrosis factor treatment","volume":"69","author":"Sfikakis","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0068","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","article-title":"Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study","volume":"5","author":"Solberg","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0069","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0016-5085(94)90054-X","article-title":"Course of ulcerative colitis: analysis of changes in disease activity over years","volume":"107","author":"Langholz","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtct.2021.03.023_bib0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN study)","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0071","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2020.02.023","article-title":"Prevalence and clinical features of inflammatory bowel diseases associated with monogenic variants, identified by whole-exome sequencing in 1000 children at a single center","volume":"158","author":"Crowley","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtct.2021.03.023_bib0072","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0961203319836717","article-title":"Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients","volume":"28","author":"Jesus","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jtct.2021.03.023_bib0073","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/1756-185X.13110","article-title":"Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients","volume":"21","author":"Dhaon","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jtct.2021.03.023_bib0074","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ibd.21400","article-title":"Short CDAI: development and validation of a shortened and simplified Crohn's Disease Activity Index","volume":"17","author":"Thia","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jtct.2021.03.023_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2377-14-58","article-title":"Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis","volume":"14","author":"Meyer-Moock","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0076","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/pedi.12895","article-title":"Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome","volume":"20","author":"Yamauchi","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jtct.2021.03.023_bib0077","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.03.023_bib0078","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/bmt.2015.294","article-title":"Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations","volume":"51","author":"Snarski","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0079","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0080","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2019.02.014","article-title":"Autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis: position statement from the American Society for Blood and Marrow Transplantation","volume":"25","author":"Cohen","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0081","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.03.023_bib0082","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.03.023_bib0083","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.03.023_bib0084","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2018.18743","article-title":"Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial","volume":"321","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.03.023_bib0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/08916930802198550","article-title":"Stem cell transplantation in rheumatoid arthritis","volume":"41","author":"Snowden","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtct.2021.03.023_bib0086","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2015.16700","article-title":"Autologous hematopoietic stem cell transplantation for refractory Crohn disease: a randomized clinical trial","volume":"314","author":"Hawkey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.03.023_bib0087","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","article-title":"Management of autoimmune diseases after haematopoietic stem cell transplantation","volume":"157","author":"Holbro","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0088","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood-2012-07-445965","article-title":"New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation","volume":"121","author":"Daikeler","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.023_bib0089","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bbmt.2018.03.029","article-title":"High incidence of autoimmune disease after hematopoietic stem cell transplantation for chronic granulomatous disease","volume":"24","author":"Yanir","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0090","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.cgh.2014.11.026","article-title":"Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission","volume":"13","author":"Papamichael","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0091","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2017.03.008","article-title":"Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review","volume":"16","author":"Leone","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtct.2021.03.023_bib0092","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.023_bib0093","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(19)30031-6","article-title":"Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial","volume":"6","author":"Bola\u00f1os-Meade","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2021.03.023_bib0094","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","article-title":"Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia","volume":"23","author":"DeZern","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0095","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bbmt.2018.03.031","article-title":"Haploidentical peripheral blood stem cell transplantation demonstrates stable engraftment in adults with sickle cell disease","volume":"24","author":"Saraf","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0096","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41409-018-0111-y","article-title":"Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial","volume":"53","author":"Ozdogu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.023_bib0097","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.03.023_bib0098","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721008009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721008009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T01:05:01Z","timestamp":1725325501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721008009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2666636721008009"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.03.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}